Hca healthcare's sarah cannon cancer institute implements new outpatient model for car t-cell therapy

Nashville, tenn.--(business wire)--hca healthcare, inc. (nyse:hca), one of the nation's leading healthcare providers, today announced that the sarah cannon cancer institute (scci) of hca healthcare has successfully established an integrated management process that safely transitioned more than 75% of hca healthcare's car t-cell therapy patients into an outpatient setting for monitoring. the program model resulted in more than 1,200 hospital bed days saved for the first 100 patients of the progr.
HCA Ratings Summary
HCA Quant Ranking